Target intelligence / Profile preview

UBX domain protein 2B pseudogene

Overview

UBX domain protein 2B pseudogene" (ENSG00000236018) is not recognized as a canonical protein-coding gene or validated therapeutic target. There is no functional, biological, or pharmacological data supporting its relevance as a drug target or biomarker. The well-characterized gene in this protein family is UBX domain protein 2B (UBXN2B, Ensembl ID: ENSG00000215114), which encodes a functional protein involved in Golgi and endoplasmic reticulum biogenesis and is not itself a pseudogene. No authoritative sources support therapeutic targeting or biological roles for a UBXN2B pseudogene. This entry likely results from a misannotation or database artifact and should not be treated as a valid therapeutic target.

Beyond the preview

Go deeper on UBX domain protein 2B pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UBX domain protein 2B pseudogene.

Explore the full profile